In a late-stage trial of 126 patients, people with acute myeloid leukemia who got an experimental vaccine lived a median of 24 months, compared with 14.7 months for those on the best available treatment.
The vaccine trains the immune system to hunt down leftover cancer cells, and it was tested in patients in remission who couldn’t get a bone marrow or stem-cell transplant.
Read: https://theglobalfilipinomagazine.com/new-vaccine-helps-blood-cancer-patients-live-more-than-nine-months-longer-study-finds/
